Novartis Explores Virtual Reality Tools In Drug Discovery R&D
Virtual reality (VR) has been a hot topic in game industry lately, but now it finds its way to biopharmaceutical …
Latest Insights
Takeda Partners With Numerate To Use Artificial Intelligence For Drug Discovery
A multi-year research agreement has just been announced between Takeda Pharmaceuticals (TSE: 4502) and an Artificial Intelligence (AI)-driven computational drug …
8 Biopharma Trends and Top Startups to Follow in 2017
Pharmaceutical industry is rapidly evolving, influenced by emerging novel technologies and recent advances in Life Sciences and Big Data analysis, …
Unveiling Hidden Drug Targets
Scientists estimated that the human genome encodes above 20,000 different proteins in our body. However, available public databases contain records …
The Power Of Machine Learning For Drug Discovery
An IBM’s executive Deborah DiSanzo just announced a collaboration with a pharmaceutical giant Pfizer to speed up anticancer drug discovery. This is …
Chinese Biotech Innovent Biologics, Inc. Raises USD 260M To Accelerate Biologics Development
Chinese biopharmaceutical industry investment landscape has been marked by a new record -- USD $260M Series D investment raised by …
Learning From Nature: New Antibiotics Found In Our Body
To date, nature has been the best teacher for drug discovery scientists, especially for those who develop antimicrobial drugs. Lately, …
A New Player In The Area Of Anti-inflammatory Therapeutics: Biotech Startup Inflazome To Tackle The Problem
Understanding and controlling inflammation processes has become a central goal in modern medical research. A number of companies developing novel …
Artificial Intelligence Empowers Drug Discovery: New AI-startups Focus On Biotech
In 1997 a remarkable event caught everybody’s attention - the then champion of the world Garry Kasparov lost a tournament to …
A Drug Repurposing Case By Biotech Startup Forty Seven Inc
Drug repositioning is a smart and cost-effective approach used by some pharmaceutical companies to re-invent their previously successful drugs in …
Cross-Coupling Hits The Big Time Again
Recently, a series of papers emerged in scientific press significantly expanding capabilities of classical carbon-heteroatom cross-coupling reactions making them simpler, …
A Second Chance for Integrins: Biotech Startup Morphic Therapeutic Reinvents Old Target
Integrins are a group of transmembrane receptors playing a major role in cell-cell and cell-extracellular matrix (ECM) interactions. When triggered, …